| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |